SPY424.17-1.10 -0.26%
DIA343.06-1.24 -0.36%
IXIC14,079.97-94.18 -0.66%

BRIEF-ALX Oncology Announces First Patient Dosed In ASPEN-03

05/10/2021 07:51
BRIEF-ALX Oncology Announces First Patient Dosed In ASPEN-03

- ALX Oncology Holdings Inc ALXO.O:

  • ALX ONCOLOGY ANNOUNCES FIRST PATIENT DOSED IN ASPEN-03, A PHASE 2 STUDY OF ALX148 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) FOR THE TREATMENT OF PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA

Source text for Eikon: ID:nGNX24LPqs

Further company coverage: ALXO.O


(([email protected];))